Celldex Therapeutics, Inc.·4

Jun 17, 4:16 PM ET

Wright Richard M. 4

4 · Celldex Therapeutics, Inc. · Filed Jun 17, 2024

Insider Transaction Report

Form 4
Period: 2024-06-13
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2024-06-13+65,00065,000 total
    Exercise: $36.43From: 2025-06-13Exp: 2034-06-13Common Stock (65,000 underlying)
Footnotes (2)
  • [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
  • [F2]25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.

Documents

1 file
  • 4
    form4-06172024_080608.xmlPrimary